Evidence map›Paper›PMID 22162748›Full record

ArticlePloS one2011

Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis.

Nina A Martin, Sarah K Mount Patrick, Teresa E Estrada, Harrison A Frisk, Daniel T Rogan, Bohuslav Dvorak, Melissa D Halpern

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. American journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Intestinal epithelium in early life.Mucosal immunology · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Human breast milk exosomes attenuate intestinal damage.Pediatric surgery international · 2020
    Article
  15. Article
  16. Review
  17. Necrotizing enterocolitis: It's not all in the gut.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  18. Review
  19. Innate and adaptive immunity in necrotizing enterocolitis.Seminars in fetal & neonatal medicine · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nina A MartinDepartment of Pediatrics and Steele Children's Research Center, University of Arizona, Tucson, Arizona, USA.
Sarah K Mount Patrick
Teresa E Estrada
Harrison A Frisk
Daniel T Rogan
Bohuslav Dvorak
Melissa D Halpern
University of Arizona · US

Funding

BILE ACIDS IN THE PATHOGENESIS OF NECROTIZING ENTEROCOLITISR01HD054485 · NICHD · UNIVERSITY OF ARIZONA · PI HALPERN, MELISSA D · 2007 to 2011
$1.7M
Howard Hughes Medical Institute 52005889NICHD NIH HHS R01 HD054485NICHD NIH HHS R01 HD-54485
6 · The paper itself

Abstract

Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency of premature infants, but its etiology remains unclear. We have previously shown that mucin 2 (Muc2) positive goblet cells are significantly decreased in NEC. We have also shown that ileal bile acids (BAs) are significantly increased during the development of this disease. Because BAs can affect mucins, we hypothesized that elevated ileal BAs contribute to decreased Muc2 in experimental NEC. The role of Muc2 in NEC was evaluated in Winnie +/+ mice, a strain that produces aberrant Muc2. Muc2 and trefoil factor 3 (Tff3) were assessed in neonatal rats subjected to the NEC protocol when bile acids were removed, and in ileal explants from newborn and older rats cultured with and without BAs. Further, the role of active transport of BAs was determined using neonatal rats given the apical sodium dependent bile acid transporter (Asbt) inhibitor SC-435 and in neonatal Asbt knockout mice subjected to the NEC protocol. Mice with aberrant Muc2 had significantly greater incidence and severity of NEC. Using both in vivo and ex vivo techniques, we determined that BAs decrease Muc2 positive cells in neonatal but not older ileum. However, Tff3 positive cells are not decreased by BAs. In addition, active transport of BAs is required for BAs to decrease Muc2 in immature ileum. These data show that functional Muc2 plays a critical role in the prevention of NEC and BAs can potentiate the decreased Muc2 in disease development. Further, BAs have a more profound effect on Muc2 in immature versus older ileum, which may explain at least in part why NEC occurs almost exclusively in premature infants.

Indexed as

Gene Expression RegulationAnimalsBile Acids and SaltsBiological TransportCholestyramine ResinEnterocolitis, NecrotizingIleumMiceMice, KnockoutMice, TransgenicModels, BiologicalMucin-2RatsRats, Sprague-DawleyTime FactorsBile Acids and SaltsCholestyramine ResinMucin-2

Identifiers

PMID22162748
PMCPMC3230578
OpenAlexW2027728493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.